Defining the therapeutic reference range for cariprazine
Introduction According to the Consensus Guideline, the “therapeutic reference range” (TRR) defines ranges of drug blood concentrations that specify a lower limit below which a drug-induced therapeutic response is unlikely to occur and an upper limit above which tolerability decreases or the therape...
Main Authors: | M. Kapás, A. Horváth, D. Djuric, R. Csehi, Á. Barabássy |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823011781/type/journal_article |
Similar Items
-
Benzodiazepine use during cariprazine treatment in acute schizophrenia
by: C. Correll, et al.
Published: (2022-06-01) -
Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
by: R. Mcintyre, et al.
Published: (2022-06-01) -
The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials
by: P. Falkai, et al.
Published: (2022-06-01) -
Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials
by: R. S. McIntyre, et al.
Published: (2023-03-01) -
The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
by: Reka Csehi, et al.
Published: (2023-12-01)